Mphelekedzeni Mangwane-Mulaudzi

Mphelekedzeni Mangwane-Mulaudzi

Auto-generated profile, based on publicly available information

Mphelekedzeni Mangwane-Mulaudzi

Kalafong Hospital, University of Pretoria, Pretoria, South Africa

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Lancet Global Health
Verified
Journal Article
Open access
Bolajoko OlusanyaBolajoko Olusanya
Bolajoko Olusanya
ADAdrian C. Davis
Adrian C. Davis
DWDonald Wertlieb
Donald Wertlieb
NBNem-Yun Boo
Nem-Yun Boo
MNM.K.C. Nair
M.K.C. Nair
NKNicholas J. Kassebaum
Nicholas J. Kassebaum
The Sustainable Development Goals (SDGs) mandate systematic monitoring of the health and wellbeing of all children to achieve optimal early childhood development. However, global epidemiological data on children with developmental disabilities are scarce. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 provides a comprehensive assessment of prevalence and years lived with disability (YLDs) for development disabilities among children younger than 5 years in 195 countries and territories from 1990 to 2016. We estimated prevalence and YLDs for epilepsy, intellectual disability, hearing loss, vision loss, autism spectrum disorder, and attention deficit hyperactivity disorder. YLDs were estimated as the product of the prevalence estimate and the disability weight for each mutually exclusive disorder, corrected for comorbidity. We used DisMod-MR 2.1, a Bayesian meta-regression tool, on a pool of primary data derived from systematic reviews of the literature, health surveys, hospital and claims databases, cohort studies, and disease-specific registries. Globally, 52·9 million (95% uncertainty interval [UI] 48·7-57·3; or 8·4% [7·7-9·1]) children younger than 5 years (54% males) had developmental disabilities in 2016 compared with 53·0 million (49·0-57·1; or 8·9% [8·2-9·5]) in 1990. About 95% of these children lived in low-income and middle-income countries. YLDs among these children increased from 3·8 million (95% UI 2·8-4·9) in 1990 to 3·9 million (2·9-5·2) in 2016. These disabilities accounted for 13·3% of the 29·3 million YLDs for all health conditions among children younger than 5 years in 2016. Vision loss was the most prevalent disability, followed by hearing loss, intellectual disability, and autism spectrum disorder. However, intellectual disability was the largest contributor to YLDs in both 1990 and 2016. Although the prevalence of developmental disabilities among children younger than 5 years decreased in all countries (except for North America) between 1990 and 2016, the number of children with developmental disabilities increased significantly in sub-Saharan Africa (71·3%) and in North Africa and the Middle East (7·6%). South Asia had the highest prevalence of children with developmental disabilities in 2016 and North America had the lowest. The global burden of developmental disabilities has not significantly improved since 1990, suggesting inadequate global attention on the developmental potential of children who survived childhood as a result of child survival programmes, particularly in sub-Saharan Africa and south Asia. The SDGs provide a framework for policy and action to address the needs of children with or at risk of developmental disabilities, particularly in resource-poor countries. The Bill & Melinda Gates Foundation.

1 March 2018 in The Lancet Global Health
Verified
Journal Article
Open access
IEIlgi Ozturk Ertem
Ilgi Ozturk Ertem
VKVibha Krishnamurthy
Vibha Krishnamurthy
MMMphelekedzeni C Mulaudzi
Mphelekedzeni C Mulaudzi
YSYanina Sguassero
Yanina Sguassero
HBHakan Balta
Hakan Balta
BFBrian W C Forsyth
Brian W C Forsyth
Knowledge about typical development is of fundamental importance for understanding and promoting child health and development. We aimed to ascertain when healthy children in four culturally and linguistically different countries attain developmental milestones and to identify similarities and differences across sexes and countries. In this cross-sectional, observational study, we recruited children aged 0-42 months and their caregivers between March 3, 2011, and May 18, 2015, at 22 health clinics in Argentina, India, South Africa, and Turkey. We obtained a healthy subsample, which excluded children with a low birthweight, perinatal complications, chronic illness, undernutrition, or anaemia, and children with missing health data. Using the Guide for Monitoring Child Development, caregivers described their child's development in seven domains: expressive and receptive language, gross and fine motor, play, relating, and self-help. Clinicians examining the children also completed a checklist about the child's health status. We used logit and probit regression models based on the lowest deviance information criterion to generate Bayesian point estimates and 95% credible intervals for the 50th percentile ages of attainment of 106 milestones. We assessed the significance of differences between sexes and countries using predefined criteria and regions of practical equivalence. Of 10 246 children recruited, 4949 children (48·3%) were included in the healthy subsample. For the 106 milestones assessed, the median age of attainment was equivalent for 102 (96%) milestones across sexes and 81 (76%) milestones across the four countries. Across countries, median ages of attainment were equivalent for all play milestones, 20 (77%) of 26 expressive language milestones, ten (67%) of 15 receptive language milestones, nine (82%) of 11 fine motor milestones, 14 (88%) of 16 gross motor milestones, and eight (73%) of 11 relating milestones. However, across the four countries the median age of attainment was equivalent for only two (22%) of nine milestones in the self-help domain. The ages of attainment of developmental milestones in healthy children, and the similarities and differences across sexes and country samples might aid the development of international tools to guide policy, service delivery, and intervention research, particularly in low-income and middle-income countries. Eunice Kennedy Shriver National Institute of Child Health and Human Development.

25 November 2018 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
IEIlgi Ozturk Ertem
Ilgi Ozturk Ertem
VKVibha Krishnamurthy
Vibha Krishnamurthy
MMMphelekedzeni C. Mulaudzi
Mphelekedzeni C. Mulaudzi
YSYanina Sguassero
Yanina Sguassero
BBBurcu Bilik
Burcu Bilik
BFBrian W.C. Forsyth
Brian W.C. Forsyth

1 November 2018 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
Bolajoko OlusanyaBolajoko Olusanya
Bolajoko Olusanya
MGMelissa Gladstone
Melissa Gladstone
JRJean Paul Rukabyarwema
Jean Paul Rukabyarwema
HKHannah Kuper
Hannah Kuper
MMMphelekedzeni C. Mulaudzi
Mphelekedzeni C. Mulaudzi
PVPetrus J. de Vries
Petrus J. de Vries

25 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
Bolajoko OlusanyaBolajoko Olusanya
Bolajoko Olusanya
JOJacob Olusanya
Jacob Olusanya
FOFelix A. Ogbo
Felix A. Ogbo
TSTracey Smythe
Tracey Smythe
MMMphelekedzeni Mangwane-Mulaudzi
Mphelekedzeni Mangwane-Mulaudzi
MGMelissa J. Gladstone
Melissa J. Gladstone
Background: Mortality among children under 5 years in sub-Saharan Africa (SSA) has declined substantially since 2000, but progress in the developmental status of surviving children under the Sustainable Development Goals, 2015-2030 (SDGs) remains unclear. This paper examines mortality and disability among children under 5 years in SSA to inform regional global health priorities. Methods: We conducted a sub-regional and national analysis of the Global Burden of Disease Study (GBD) 2023 for all 48 countries in SSA to compare changes in all-cause mortality, developmental disabilities, and Years Lived with Disability (YLDs) between 2000 and 2023. The prevalence of attention-deficit/hyperactivity disorder, autism spectrum disorder, developmental intellectual disability, epilepsy, hearing loss, vision loss and aggregate disabilities in 2023 was also analysed. Estimates are reported with 95% uncertainty intervals. Findings: Whereas child mortality declined by 31.1% (30.0 to 32.2) from 3.8 million (95% UI:3.8–3.9) in 2000 to 2.6 million (2.6–2.7) in 2023, the number of children with a disability rose by 67.0% (22.9–127.1) from 7.0 million (6.0–8.5) in 2000 to 11.6 million (9.6–15.9) in 2023, representing a 6.4% (5.3-8.7) prevalence. YLDs rose by 74.3% (1.5–199.2) from 0.8 million (0.6–1.1) to 1.4 million (1.0–2.3) within this period. In 2023, the prevalence of developmental disabilities and YLDs was greatest in Eastern SSA. Some 61.2% of children with disabilities resided in the ten top countries, collectively accounting for 67.2% of the region’s child mortality. Nigeria, the Democratic Republic of Congo, and Ethiopia accounted for the most overlapping burden of child mortality and disability. Hearing loss was the most prevalent disability (2.4% [2.1-2.6]), affecting 4.3 million (3.8–4.8) children. Epilepsy was associated with the greatest YLDs. Interpretation: The growing burden of developmental disabilities in SSA calls for global action to place the affected children on a trajectory for optimal development and inclusive learning, as mandated by the SDGs. Improved primary data sources and surveillance systems are also required for more precise disability estimates.